Literature DB >> 15504878

Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany.

Kirsten Fluegge1, Sven Supper, Anette Siedler, Reinhard Berner.   

Abstract

The antimicrobial susceptibility of 296 invasive neonatal group B streptococcus isolates from a nationwide 2-year surveillance study in Germany was investigated. All isolates were susceptible to beta-lactams, linezolid, quinupristin-dalfopristin, and vancomycin. Erythromycin and clindamycin resistance was found in 10.1 and 5.7%, respectively. The ermB, ermTR, or mefA gene was detected in all but one of the erythromycin-resistant isolates.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15504878      PMCID： PMC525390          DOI： 10.1128/AAC.48.11.4444-4446.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  29 in total

1.  Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital.

Authors:  Claire Poyart; Laurence Jardy; Gilles Quesne; Patrick Berche; Patrick Trieu-Cuot
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

2.  Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance.

Authors:  J Kataja; P Huovinen; M Skurnik; H Seppälä
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

3.  Antibiotic susceptibility profile of group B streptococcus acquired vertically.

Authors:  D J Rouse; W W Andrews; F Y Lin; C W Mott; J C Ware; J B Philips
Journal:  Obstet Gynecol       Date:  1998-12       Impact factor: 7.661

4.  Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis.

Authors:  M Fernandez; M E Hickman; C J Baker
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

5.  Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci.

Authors:  C Betriu; M Gomez; A Sanchez; A Cruceyra; J Romero; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

6.  High-level chromosomal gentamicin resistance in Streptococcus agalactiae (group B).

Authors:  A Buu-Hoï; C Le Bouguenec; T Horaud
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

7.  Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes.

Authors:  J Clancy; J Petitpas; F Dib-Hajj; W Yuan; M Cronan; A V Kamath; J Bergeron; J A Retsema
Journal:  Mol Microbiol       Date:  1996-12       Impact factor: 3.501

8.  A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes.

Authors:  H Seppälä; M Skurnik; H Soini; M C Roberts; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

9.  Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae.

Authors:  C Betriu; E Culebras; M Gómez; I Rodríguez-Avial; B A Sánchez; M C Agreda; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

10.  Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin.

Authors:  M D Pearlman; C L Pierson; R G Faix
Journal:  Obstet Gynecol       Date:  1998-08       Impact factor: 7.661
View more
  14 in total

1.  Association between resistance to erythromycin and the presence of the fibronectin binding protein F1 gene, prtF1, in Streptococcus pyogenes isolates from German pediatric patients.

Authors:  Maria Haller; Kirsten Fluegge; Sandra Jasminder Arri; Brit Adams; Reinhard Berner
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

2.  Dominance of serotype Ia among group B Streptococci causing invasive infections in nonpregnant adults in Portugal.

Authors:  E R Martins; J Melo-Cristino; M Ramirez
Journal:  J Clin Microbiol       Date:  2012-01-04       Impact factor: 5.948

3.  Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy.

Authors:  M A De Francesco; S Caracciolo; F Gargiulo; N Manca
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-26       Impact factor: 3.267

4.  Significant decline in the erythromycin resistance of group A streptococcus isolates at a German paediatric tertiary care centre.

Authors:  S Farmand; P Henneke; M Hufnagel; R Berner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-28       Impact factor: 3.267

5.  Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil.

Authors:  Jussara K Palmeiro; Libera M Dalla-Costa; Sérgio E L Fracalanzza; Ana C N Botelho; Keite da Silva Nogueira; Mara C Scheffer; Rosângela S L de Almeida Torres; Newton Sérgio de Carvalho; Laura Lúcia Cogo; Humberto M F Madeira
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

6.  Cross-resistance to lincosamides, streptogramins A, and pleuromutilins due to the lsa(C) gene in Streptococcus agalactiae UCN70.

Authors:  Brigitte Malbruny; Anja M Werno; David R Murdoch; Roland Leclercq; Vincent Cattoir
Journal:  Antimicrob Agents Chemother       Date:  2011-01-18       Impact factor: 5.191

7.  In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae.

Authors:  Giorgio Piccinelli; Prabhavathi Fernandes; Carlo Bonfanti; Francesca Caccuri; Arnaldo Caruso; Maria Antonia De Francesco
Journal:  Antimicrob Agents Chemother       Date:  2013-12-30       Impact factor: 5.191

8.  Clinical update on linezolid in the treatment of Gram-positive bacterial infections.

Authors:  Sally Ager; Kate Gould
Journal:  Infect Drug Resist       Date:  2012-06-25       Impact factor: 4.003

9.  Antibiotic resistance of Streptococcus agalactiae isolated from pregnant women in Garankuwa, South Africa.

Authors:  John Y Bolukaoto; Charles M Monyama; Martina O Chukwu; Sebotse M Lekala; Maphoshane Nchabeleng; Motlatji R B Maloba; Rooyen T Mavenyengwa; Sogolo L Lebelo; Sam T Monokoane; Charles Tshepuwane; Sylvester R Moyo
Journal:  BMC Res Notes       Date:  2015-08-20

10.  Antibiotic susceptibility patterns and prevalence of group B Streptococcus isolated from pregnant women in Misiones, Argentina.

Authors:  M Quiroga; E Pegels; P Oviedo; E Pereyra; M Vergara
Journal:  Braz J Microbiol       Date:  2008-06-01       Impact factor: 2.476
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.